ACNS0332: Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients

ID Number 80-0066-00332

Principal Investigator(s)
Birte Wistinghausen

Department(s) or Division(s)
Hematology and Medical Oncology


The overall goal of this study is to compare the effects, good and/or bad, of the chemotherapy drugs carboplatin and isotretinoin on subjects with high risk medulloblastoma and to find out if one or both are better than standard therapy alone.

In this study you will get either standard therapy alone, standard therapy plus one of the chemotherapy drugs added to the regimen, or standard therapy plus both of the chemotherapy drugs.

Contact Information
Dr. Birte Wistinghausen
(212) 824-7309

Recruiting Patients: Yes